Stock Report Sun Pharma Advanced Research Company Ltd. with In-Depth Stock Analysis

Sun Pharma Advanced Research Company Ltd. NSE: SPARC | BSE: 532872

162.04 5.21 (3.32%)

7.3M NSE+BSE Volume

NSE 05 Jun, 2025 3:31 PM (IST)

Trial Setback

SPARC ends Vibozilimod drug development after it fails to meet key goals in phase-2 trials See details

Detailed Stock Analysis for Sun Pharma Advanced Research Company Ltd. with Real-time Stock Report